We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

53 hedge funds and large institutions have $122M invested in Fibrocell Science Inc. in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less funds holding

Funds holding: 5553 (-2)

16% less capital invested

Capital invested by funds: $145M → $122M (-$22.7M)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

49% less call options, than puts

Call options by funds: $18K | Put options by funds: $35K

Holders
53
Holders Change
-2
Holders Change %
-3.64%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
26
Reduced
14
Closed
7
Calls
$18K
Puts
$35K
Net Calls
-$17K
Net Calls Change
-$85K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$64M +$5.76M +65,066 +6%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$13.9M
Jennison Associates
3
Jennison Associates
New York
$10.8M +$902K +10,195 +6%
MP
4
MSD Partners
New York
$7.69M +$1.59M +18,000 +16%
QF
5
QVT Financial
New York
$7.2M +$11M +124,704 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.15M +$1.03M +11,678 +27%
BFA
7
BlackRock Fund Advisors
California
$2.6M +$164K +1,854 +4%
EA
8
Emerald Advisers
Pennsylvania
$1.25M +$483K +5,458 +34%
BIT
9
BlackRock Institutional Trust
California
$1.12M +$684K +7,730 +66%
Invesco
10
Invesco
Georgia
$1.06M +$1.62M +18,304 +28,600%
Northern Trust
11
Northern Trust
Illinois
$1.04M +$1.25M +14,120 +370%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$793K +$113K +1,278 +10%
State Street
13
State Street
Massachusetts
$760K +$193K +2,178 +20%
Cambridge Investment Research Advisors
14
Cambridge Investment Research Advisors
Iowa
$754K +$1.16M +13,057 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$601K -$78.9K -891 -8%
HVC
16
Healthcare Value Capital
New Jersey
$569K -$59K -667 -6%
TMC
17
Trellus Management Company
Florida
$443K
SCA
18
STALEY CAPITAL ADVISERS
Pennsylvania
$423K
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$420K +$82.7K +934 +15%
BIM
20
BlackRock Investment Management
Delaware
$355K +$43.7K +494 +9%
CCA
21
Catalyst Capital Advisors
New York
$344K -$443K -5,000 -46%
SIP
22
Stoneridge Investment Partners
Pennsylvania
$331K -$29.9K -338 -6%
TCIM
23
TIAA CREF Investment Management
New York
$316K +$27K +305 +6%
Citigroup
24
Citigroup
New York
$212K -$1.86K -21 -0.6%
ACM
25
Akanthos Capital Management
California
$192K +$295K +3,333 New

FCSC Hedge Fund Activity: Q3 2015 in Review

53 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2015, worth a combined $122M — down 16% from $145M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of FCSC and 5 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 26 added.

The largest buyer was QVT Financial, opening a new position worth an estimated $11M. The largest seller was Belmont Global Advisors, exiting entirely with an estimated $509K sold.

  • 53 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2015, down from 55 in Q2 2015.
  • Funds reported $122M of Fibrocell Science Inc. stock for Q3 2015, down 16% quarter-over-quarter.
  • 5 funds opened new Fibrocell Science Inc. positions in Q3 2015 and 7 closed out, a net change of -2 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2015 was QVT Financial, an estimated $11M added.
  • The largest Fibrocell Science Inc. seller in Q3 2015 was Belmont Global Advisors, an estimated $509K sold.

Based on aggregated 13F filings for Q3 2015.